Home › Ovarian Cancer › Montana › Billings
Ovarian Cancer clinical trials in Billings, MT
9 studies for Ovarian Cancer are looking for participants at sites in and around Billings (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Billings Clinic Cancer Center, Billings
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
RecruitingPhase 3
- Research Site, Billings
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
RecruitingPhase 2
- Intermountain Health - Intermountain Health West End Clinic /ID# 278470, Billings
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecruitingPhase 3
- Billings Clinic, Billings
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecruitingPhase 2
- St. Vincent Regional Hospital - West End Clinic, Billings
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- and 1 more
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- and 1 more
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- St. Vincent Gynecologic Oncology, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Billings
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Billings
- Non-Small Cell Lung Cancer17 studies
- Prostate Cancer15 studies
- Lung Cancer13 studies
- Breast Cancer10 studies
- Melanoma7 studies
- Chronic Lymphocytic Leukemia7 studies
- Acute Myeloid Leukemia7 studies
- Bladder Cancer6 studies
- Colon Cancer6 studies
- Colorectal Cancer6 studies
- Rectal Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.